Laurus Labs will benefit from the growth prospects of the global and domestic pharma indutry as spending on medicines, including Covid-19 vaccines, is likely to increase at 3-6% CAGR by 2026.from Personal Finance News-Wealth-Economic Times https://ift.tt/h6t9Onz
No comments:
Post a Comment